Ropinirole
Back to searchMolecule Structure
Scientific Name
Ropinirole
Description of the Drug
Ropinirole is a non-ergoline dopamine agonist used to treat the symptoms of Parkinson’s disease and Restless Legs Syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00268
http://www.drugbank.ca/drugs/DB00268
Brand Name(s)
Requip
Company Owner(s)
Epic Pharma Llc, Cadila Healthcare Ltd, Glenmark Generics Ltd, Alembic Pharmaceuticals Ltd, Mlv Pharma Llc, Celltrion Inc, Sandoz Inc, Watson Laboratories Inc, Actavis Elizabeth Llc, Accord Healthcare Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | AGONIST | CHEMBL2331075 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL35212 | ||
| PharmGKB | PA164749035 | ||
| Human Metabolome Database | HMDB0014413 | ||
| DrugBank | DB00268 | ||
| PubChem: Thomson Pharma | 15221518 | ||
| PubChem | 5095 | ||
| Mcule | MCULE-1333778454 | ||
| LINCS | LSM-2351 | ||
| Nikkaji | J264.965I | ||
| BindingDB | 50020680 | ||
| EPA CompTox Dashboard | DTXSID8045195 | ||
| DrugCentral | 2402 | ||
| Guide to Pharmacology | 7295 | ||
| rxnorm | REQUIP | ROPINIROLE HYDROCHLORIDE | ROPINIROLE |
| KEGG Ligand | C07564 | ||
| ChEBI | 8888 | ||
| ZINC | ZINC000000002041 |
